General Information of DFM (ID: F23409)
Name
Cyclosporine 25mg capsule
Company
Novartis
Active Pharmaceutical Ingredient (API) Cyclosporin A API Info click to show the detail info of this API
Rheumatoid arthritis ICD-11: FA20 Approved
Drug Inactive Ingredient (DIGs)
DIG ID DIG Info DIG Name DIG Functional Class
E0SF4Y DIG Info Ethanol Antimicrobial preservative ...
E0M0IE DIG Info Ferric hydroxide oxide yellow Colorant
E00FTX DIG Info Gelatin Other agent
E06WYP DIG Info Glycerin Antimicrobial preservative ...
E0L1TV DIG Info Haematite red Colorant
E0G5FT DIG Info Sorbitan tristearate Dispersing agent ...
E05BSD DIG Info Titanium dioxide Coating agent ...
E0I4VY DIG Info Triolein Complexing agent ...
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM
      Oxidoreductase (ORase)
            DBT Name: Cytochrome P450 2E1 (CYP2E1) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Gelatin
                    Biological Activity IC50 = 141.2 uM (tested by experiment) [1]
                    Tested Species Homo sapiens (Human)
                    UniProt ID CP2E1_HUMAN
            DBT Name: Cytochrome P450 2C9 (CYP2C9) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Gelatin
                    Biological Activity EC50 = 249.5 uM (tested by experiment) [1]
                    Tested Species Homo sapiens (Human)
                    UniProt ID CP2C9_HUMAN
            DBT Name: Mephenytoin 4-hydroxylase (CYP2C19) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Gelatin
                    Biological Activity EC50 = 20.5 uM (tested by experiment) [1]
                    Tested Species Homo sapiens (Human)
                    UniProt ID CP2CJ_HUMAN
            DBT Name: Debrisoquine 4-hydroxylase (CYP2D6) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Gelatin
                    Biological Activity EC50 = 379.9 uM (tested by experiment) [1]
                    Tested Species Homo sapiens (Human)
                    UniProt ID CP2D6_HUMAN
      Hydrolase (HDase)
            DBT Name: Oleamide hydrolase 1 (FAAH) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Triolein
                    Biological Activity IC50 = 11000 nM (estimated based on the structural similarity with CHEMBL230967 ) [2]
                    Structural Similarity Tanimoto coefficient = 0.93442623
                    Tested Species Rattus norvegicus (Rat)
                    UniProt ID FAAH1_RAT
      Lyase/isomerase/ligase (L/I/G)
            DBT Name: Cholesterol 25-hydroxylase (CYP1A2) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Gelatin
                    Biological Activity IC50 = 40.9 uM (tested by experiment) [1]
                    Tested Species Homo sapiens (Human)
                    UniProt ID CP1A2_HUMAN
References
1 Mediation of in vitro cytochrome p450 activity by common pharmaceutical excipients. Mol Pharm. 2013 Jul 1;10(7):2739-48.
2 Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. J Med Chem. 2007 Oct 4; 50(20):5012-23.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.